Armata Pharmaceuticals, Inc. — Director's Dealing 2005

Aug 10, 2005

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TARGETED GENETICS CORP /WA/ (TGEN)
CIK: 0000921114
Period of Report: 2005-08-08

Reporting Person: BIOGEN IDEC INC (10% Owner)
Reporting Person: BIOGEN IDEC MA INC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2005-08-08	Common Stock, $0.01 Par Value	S	8443	$0.76	Disposed	11760305	Indirect
2005-08-08	Common Stock, $0.01 Par Value	S	2310	$0.761	Disposed	11757995	Indirect
2005-08-08	Common Stock, $0.01 Par Value	S	2500	$0.77	Disposed	11755495	Indirect
2005-08-09	Common Stock, $0.01 Par Value	S	2000	$0.75	Disposed	11753495	Indirect
2005-08-09	Common Stock, $0.01 Par Value	S	3000	$0.7511	Disposed	11750495	Indirect
2005-08-09	Common Stock, $0.01 Par Value	S	7200	$0.76	Disposed	11743295	Indirect

Footnotes

F1: Shares are owned indirectly by Biogen Idec Inc. and directly by its wholly-owned subsidiary Biogen Idec MA Inc., fka Biogen, Inc.